GEN17h
A Call to Action: Building Vaccine Trust Through Transparency
It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...
Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
SchaeffersResearch.com1d
Moderna Stock Falls on Vaccine Revenue Concerns
Shares of Moderna Inc. (NASDAQ: MRNA) are down 3.2% in premarket trading after a bear note from Goldman Sachs. The firm lowered its rating on MRNA to "neutral" from "buy," and nearly halved its price ...
Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
RFK Jr. reportedly softens his antivaccine stance ahead of confirmation hearing
Ahead of his confirmation hearing this week, Robert F. Kennedy Jr., President Donald Trump’s nominee for HHS Secretary, has ...
Scientists call for more research on Covid vaccine heart side effects
Experts University of British Columbia called for more research on Covid vaccines and heart conditions like myocarditis and ...